In this free webinar, learn about the current and future state of the bioanalysis of oligonucleotides. Attendees will gain insights into common approaches to the bioanalysis of oligonucleotides. The featured speaker will discuss evaluating and selecting the optimal and strategic approach.
TORONTO, Ontario, July 6, 2023 /PRNewswire-PRWeb/ -- To enhance knowledge and understanding in the field of bioanalysis, there will be a free, upcoming webinar titled "Oligonucleotides: A Bioanalytical CRO's Perspective on Current and Future State". This event promises to shed light on the current and future states of oligonucleotides in drug development and bioanalytical analysis.
Since the approval of the first oligonucleotide drug by the US Food and Drug Administration (FDA) in 1998, the industry has made notable strides in the advancement of techniques, technology and development methods; however, the inherent complexity and sensitivity of oligonucleotides present persistent challenges that need addressing within drug development and bioanalytical analysis. The webinar will provide a comprehensive insight into these issues, discussing the common approaches to bioanalysis of oligonucleotides and evaluating the most optimal and strategic approach.
The esteemed speaker for the event is Troy Voelker, PhD, Director of Laboratory Operations at Aliri. With over 17 years of experience in the bioanalytical industry and an extensive background in synthetic organic chemistry and medicinal drug development, Dr. Voelker has a wealth of knowledge to share, particularly in oligonucleotide bioanalysis, a therapeutic class he has led the development and validation for over the past decade.
Aliri is renowned for its role as a leading bioanalytical contract research organization with locations in Colorado Springs, CO, Salt Lake City, Utah, and Loos, France. Offering a range of bioanalytical lab, spatial bioanalysis and spatial biology solutions to pharmaceutical companies, Aliri assists at all stages of the drug development process. The team's industry-leading science and regulatory compliance make it a key player in advancing molecules from discovery through clinical development and NDA approval.
As a part of their ongoing initiatives to foster learning and drive advancements in the field, Aliri is hosting this webinar in collaboration with Xtalks, a trusted partner in delivering valuable industry content.
Mark your calendars for the live webinar on Wednesday, July 19, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Oligonucleotides: A Bioanalytical CRO's Perspective on Current and Future State.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks
Share this article